drugset / Trial / NCT06732154
A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of HRS-5632 Following a Single Subcutaneous Injection in Healthy Subjects
Timeline
- Start
- 2024-12-02
- Primary completion
- 2026-03-02
- Completion
- 2026-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-5632 | Unknown | — | Subcutaneous |